Thailand’s latest research proves that a native Indonesian herb, bitter extract, has proven to be effective against the SARS CoV 2 or Coronavirus Covid-19 virus.
Chairman of the Association of Indonesian Traditional Medicine and Herbal Medicine Development Doctors (PDPOTJI), dr. Ingrid Tania said that the active compound in sambiloto such as andrographolide can inhibit the SARS CoV 2 virus from multiplying or replicating in the body.
“Andrographolide can bind to the SARS CoV 2 virus protein and through a series of mechanisms, is able to inhibit the replication of the SARS CoV 2 virus and reduce inflammation,” wrote dr. In his statement received by Suara.com, Tuesday (29/6/2021).
The Thai government has carried out clinical trials in several hospitals, to prove that bitter extract is safe for consumption by patients who are confirmed positive for COVID-19 with mild symptoms.
It is even effective in improving the patient’s condition in just 3 days of intervention with sambiloto extract and without side effects.
“If the bitter is consumed by the patient within 72 hours, after symptoms arise,” explained dr. Ingrid.
As a result, the Thai government has now approved the use of bitter extract as a complementary or complementary therapy for Covid-19 patients in 5 Thai hospitals.
“Because it is useful in reducing the severity of the outbreak and cutting medical costs,” added dr. Ingrid.
Meanwhile, research on sambiloto extract was also carried out in Indonesia, which was called bio-informatics and in vitro research to prove that Sambiloto has antiviral properties against SARS CoV 2.
“Sambiloto empirically has long been used in many countries to relieve symptoms of fever, sore throat, cough that occurs in viral infections,” concluded dr. Ingrid. [Irm]